Jan. 26th, 2009

javasaurus: (Default)
In the news today, Merck has been working on a new treatment for MS -- cladribine. It seems to increase the amount of time between relapses. The current question is whether it is safe for chronic use.

WTOP news article clicky

Profile

javasaurus: (Default)
javasaurus

June 2012

S M T W T F S
     12
3456 789
101112 13141516
17181920212223
24252627282930

Most Popular Tags

Page Summary

Style Credit

Expand Cut Tags

No cut tags
Page generated Aug. 11th, 2025 09:50 am
Powered by Dreamwidth Studios